Biopharmaceutical-discovery United States Page 3 - biopharmaceutical discovery drug manufacturing & research

TopoTarget A/S is a Denmark-based biotech company. It is focused on treatments for cancer patients and other cancer-related disorders. Its activities cover various aspects of drug development, including assay development, screening, biology, medicinal ...

Kalypsys is a clinical stage pharmaceutical company that is advancing the way drugs are discovered and developed. We seamlessly integrate our capabilities in drug discovery, medicinal chemistry and translational medicine with proprietary automated technologies ...

MorphoSys is one of the world's leading biotechnology companies focusing on fully human antibodies. With its proprietary technologies, MorphoSys is developing not only the next generation of therapeutic antibodies, but also antibodies for research and ...

DIAGENICS is a biopharmaceutical company located in Woburn (Boston), MA (USA) with its European headquarters in Duesseldorf, Germany. Our unique business model strives to build a Bridge from Science to BusinessÔ. In this way we aspire to a leading position ...

Neuro Bioscience is an emerging biotechnology company that is focused on the development and commercialization of innovative treatments to treat Central Nervous System diseases and disorders. The Company has products in development targeted against Alzheimer's ...

Genome Therapeutics is a biopharmaceutical company focused on the discovery and development of pharmaceutical and diagnostics products. The Company's first product candidate, Ramoplanin, is in a Phase III clinical trial for the prevention of bloodstream ...

Biopure Corporation (Biopure) develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body’s tissues. Hemopure [hemoglobin glutamer-250 (bovine)], or HBOC-201, is approved ...

ChemoCentryx, Inc. focuses on the discovery, development and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. The chemokine system is a complex network of molecules ...

Dynavax Technologies Corporation (Dynavax) is a biopharmaceutical company that discovers, develops and focuses on commercializing Toll-like Receptor 9 (TLR9) agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic ...

PharmaMar is a biopharmaceutical company with headquarters in Madrid (Spain) and laboratories in Cambridge (US). PharmaMar is fully owned by the Zeltia Group and traded on the Spanish Stock Exchange (ZEL) with a market capitalization of over 1,5 Billion ...

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies. PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development ...

Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) is a global biopharma company focused on research, development, production and marketing of vaccines, proteins and antibodies that prevent and treat primarily infectious diseases. Its vaccines ...

Cleveland BioLabs, Inc. (CBL) is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins. CBLI is a drug discovery and development company. CBLI’s pipeline ...

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The Company is developing product candidates to treat ...

Deltagen is a leading provider of drug discovery tools and services to the biopharmaceutical industry. Deltagen offers a suite of programs designed to enhance the efficiency of drug discovery including access to biological models as well as both small-molecule ...

Conforma Therapeutics, a San Diego-based biopharmaceutical company, is focused on the design and development of novel drugs for the treatment of cancer. Conforma's internal discovery efforts have been focused on drugs that target the cellular HSP90 family ...

MediciNova, Inc. is a bio-pharmaceutical company engaged in the acquisition and development of low molecular pharmaceutical products. The drugs under its development programs include MN-001 for the treatment of bronchial asthma, MN-221 for the treatment ...

CombinatoRx, Incorporated is a biopharmaceutical company focused on developing synergistic combinations pharmaceuticals, with a portfolio of product candidates in phase II clinical development. The Company creates product candidates with mechanisms of ...

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found ...

BioXell SpA is an Italy-based biopharmaceutical company. The Company focuses on the research, development and commercialization of therapies for various medical needs. It is active in a range of therapeutic areas, such as urology (benign prostatic hyperplasia ...

Vertex Pharmaceuticals Incorporated (Vertex) is a biotechnology company in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, lead drug candidate, is an oral hepatitis C protease ...

Cerep's mission is to provide pharmaceutical companies with high quality services in drug discovery and drug development. Cerep provides, both in Europe and in the United States, solutions allowing faster and cost effective drug discovery by identifying ...

Cyclacel Pharmaceuticals, Inc. (Cyclacel) is a development-stage biopharmaceutical company engaged in the discovery, development and commercialization of mechanism-targeted drugs to treat human cancers and other serious disorders. The Company markets ...

Zymogenetics, Inc. is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases. The Company's therapeutic focus is in the areas of hemostasis, inflammatory and autoimmune diseases ...

Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) is a global biopharma company focused on research, development, production and marketing of vaccines, proteins and antibodies that prevent and treat primarily infectious diseases. Its vaccines ...